Information:
Error:
Follow Up Medication Change
- StudyEvent: Baseline
- StudyEvent: Medizinischer Folgebogen
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Medication change
C0580105 (UMLS CUI-1)
Item
Which changes in the MS therapy have been carried out since the last visit?
integer
C2169461 (UMLS CUI [1])
CL Item
The drug dosage has been increased (1)
CL Item
The drug dose was reduced (2)
CL Item
The therapy was deposed and started new (3)
CL Item
The therapy was discontinued without replacement (4)
CL Item
Another change has been performed (99)
CL Item
Alemtuzumab (Lemtrada) (22)
C0383429 (UMLS CUI-1)
CL Item
Azathioprine (2)
C0004482 (UMLS CUI-1)
CL Item
Cyclophosphamide (4)
C0010583 (UMLS CUI-1)
CL Item
Fingolimod (Gilenya) (18)
C1699926 (UMLS CUI-1)
CL Item
Fumarate (BG-12; Tecfidera) (24)
C0058218 (UMLS CUI-1)
CL Item
COPAXONE (Copaxone) (6)
C0289884 (UMLS CUI-1)
CL Item
Immune Globulins (7)
C0021027 (UMLS CUI-1)
CL Item
Interferon ß-1A (Avonex) (19)
C0254119 (UMLS CUI-1)
C0021492 (UMLS CUI-2)
C0021492 (UMLS CUI-2)
CL Item
Interferon ß-1A SC (Rebif 22 µg, Rebif 44 µg) (20)
C0254119 (UMLS CUI-1)
CL Item
Interferon ß 1SC (Betaseron, Extavia) (21)
C0244713 (UMLS CUI-1)
CL Item
* Medication from a MS study (8)
C0013175 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
C0013227 (UMLS CUI-2)
CL Item
Methotrexate (9)
C0025677 (UMLS CUI-1)
CL Item
Mitoxantrone (10)
C0026259 (UMLS CUI-1)
CL Item
Natalizumab (Tysabri) (11)
C1172734 (UMLS CUI-1)
CL Item
Rituximab (14)
C0393022 (UMLS CUI-1)
CL Item
Teriflunomide (Aubagio) (23)
C1718383 (UMLS CUI-1)
CL Item
Cortisone (25)
C0010137 (UMLS CUI-1)
CL Item
Others... (99)
C1115771 (UMLS CUI-1)
Anderer abgesetzter Wirkstoff
Item
If other, what?
text
C2169646 (UMLS CUI [1,1])
C1115771 (UMLS CUI [1,2])
C1115771 (UMLS CUI [1,2])
Andere
Item
What change? (Please enter.)
text
C2169461 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
Item Group
Reason for change of medication
C2133636 (UMLS CUI-1)
CL Item
Side effects (1)
C0559546 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Lack effectiveness (2)
C0235828 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Another reason (99)
C3840932 (UMLS CUI-1)
C0850893 (UMLS CUI-2)
(Comment:en)
C0850893 (UMLS CUI-2)
(Comment:en)
Text Anderer Grund
Item
Please specify other reason
text
C2133636 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
CL Item
Alemtuzumab (Lemtrada) (22)
C0383429 (UMLS CUI-1)
CL Item
Azathioprine (2)
C0004482 (UMLS CUI-1)
CL Item
Cyclophosphamide (4)
C0010583 (UMLS CUI-1)
CL Item
Fingolimod (Gilenya) (18)
C1699926 (UMLS CUI-1)
CL Item
Fumarate (BG-12; Tecfidera) (24)
C0058218 (UMLS CUI-1)
CL Item
COPAXONE (Copaxone) (6)
C0289884 (UMLS CUI-1)
CL Item
Immune Globulins (7)
C0021027 (UMLS CUI-1)
CL Item
Interferon ß-1A (Avonex) (19)
C0254119 (UMLS CUI-1)
C0021492 (UMLS CUI-2)
C0021492 (UMLS CUI-2)
CL Item
Interferon ß-1A SC (Rebif 22 µg, Rebif 44 µg) (20)
C0254119 (UMLS CUI-1)
CL Item
Interferon ß 1SC (Betaseron, Extavia) (21)
C0244713 (UMLS CUI-1)
CL Item
* Medication from a MS study (8)
C0013175 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
C0013227 (UMLS CUI-2)
CL Item
Methotrexate (9)
C0025677 (UMLS CUI-1)
CL Item
Mitoxantrone (10)
C0026259 (UMLS CUI-1)
CL Item
Natalizumab (Tysabri) (11)
C1172734 (UMLS CUI-1)
CL Item
Rituximab (14)
C0393022 (UMLS CUI-1)
CL Item
Teriflunomide (Aubagio) (23)
C1718383 (UMLS CUI-1)
CL Item
Cortisone (25)
C0010137 (UMLS CUI-1)
CL Item
Others... (99)
C1115771 (UMLS CUI-1)
curth1a
Item
If other active ingredient, please describe
text
C2827774 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0026769 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
curth1ab
Item
Start: Month/year
date
C3173309 (UMLS CUI [1])
C2827774 (UMLS CUI [1]-2)
C0026769 (UMLS CUI [1]-3)
C2827774 (UMLS CUI [1]-2)
C0026769 (UMLS CUI [1]-3)
CL Item
Standard (1)
CL Item
Others (99)
andere
Item
Please specify the dose and method of administration
text
C0001555 (UMLS CUI [1])